You searched for viral vector - Page 19 of 53

Best in Biotech 25 Apr 2024

8 of the most expensive drugs in biopharma: Unraveling the costliest medications

…in people with hemophilia B by enabling the body to continuously produce factor IX. It is an adeno-associated virus (AAV) vector-based gene therapy, using an AAV5 vector to carry genetic…

April 25, 2024 - 12 minutesmins - By Willow Shah-Neville

News and Trends 14 Jul 2016

Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan

…next 12 months. Themis has successfully extended its existing license agreement with Institut Pasteur in Paris, which grants the company a broad access to a well-established virus vaccine vector technology….

July 14, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 7 Jun 2023

AAVantgarde closes €61M financing to move gene delivery program to the clinic

AAVantgarde Bio, a clinical-stage, Italian-based international biotechnology company with two proprietary adeno-associated viral (AAV) vector platforms for large gene delivery, has closed a €61 million ($65.1 million) Series A financing. …

June 7, 2023 - 3 minutesmins - By Jim Cornall

RDEB recessive dystrophic epidermolysis bullosa skin blisters

News and Trends 21 Nov 2022

New Replay HSV gene therapy company Telaria to focus on skin diseases

…vector capable of delivering up to eight times the payload of adeno-associated virus (AAV) vectors. This enables the delivery of genes too big to fit into AAV and facilitates polygenic…

November 21, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 11 Apr 2024

Seven companies leading the mRNA revolution in biotechnology

…vector. The focus of its pipeline is on cancer, infectious, and rare diseases. Its mRNA-based COVID-19 vaccine targeting SARS-2-COV-2 Omicron is in phase 3 clinical trials, whereas the one targeting…

April 11, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 29 Mar 2023

5 hearing loss biotech companies you should know about

…DB-OTO, and is an adeno-associated viral (AAV) dual vector gene therapy designed to restore hearing in individuals born with profound hearing loss as a result of the mutation of the…

March 29, 2023 - 7 minutesmins - By Willow Shah-Neville

Interview 25 Apr 2019

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

…to recognize the potential business opportunities in this area, as evidenced by the recent acquisition of cell and gene therapy viral vector manufacturer Brammer Bio by US giant Thermo Fisher…

April 25, 2019 - 11 minutesmins - By Helen Albert

News and Trends 20 Dec 2019

Freeline’s Rare Disease Gene Therapies Get €72M Series C Boost

…clot could change the lives of patients. Freeline’s therapy consists of an adenoviral vector carrying DNA encoding factor IX, a protein that helps the blood to clot. The vector delivers…

December 20, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 23 Nov 2022

FDA approves CSL gene therapy for hemophilia B

…viral vector, called an adeno-associated virus (AAV). The AAV5 vector carries the Padua gene variant of Factor IX (FIX-Padua) to the target cells in the liver, generating factor IX proteins…

November 23, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 29 Jul 2020

Covid-19 Forces Gene Therapy Companies to Shift Strategy

…to research and manufacture Covid-19 vaccines, since they often employ viral vectors to get genes into cells. These same vectors could also be used to carry genetic material from the…

July 29, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 27 May 2022

Blue Lake Biotechnology RSV vaccine gets FDA fast track

…and in 2018, U.K. company ReViral raised $55M to run two clinical trials to test whether its antiviral helped patients at high risk from RSV infections. Cover image via Shutterstockrnrn …

May 27, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jul 2017

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

…some concern. In the preview document shared yesterday, the FDA went beyond the short-term safety concern regarding cytokine storms to note the long-term risk of viral infections from the retroviral…

July 11, 2017 - 3 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

8 of the most expensive drugs in biopharma: Unraveling the costliest medications

Institut Pasteur & Austrian Biotech also join the World Zika Vaccine Plan

AAVantgarde closes €61M financing to move gene delivery program to the clinic

New Replay HSV gene therapy company Telaria to focus on skin diseases

Seven companies leading the mRNA revolution in biotechnology

5 hearing loss biotech companies you should know about

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

Freeline’s Rare Disease Gene Therapies Get €72M Series C Boost

FDA approves CSL gene therapy for hemophilia B

Covid-19 Forces Gene Therapy Companies to Shift Strategy

Blue Lake Biotechnology RSV vaccine gets FDA fast track

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!